Healthcare -
Biotechnology - NASDAQ - US
$ 3.35
0.601 %
$ 2.33 M
Market Cap
0.0
P/E
RNAZ - NET INCOME
Net Income RNAZ - TransCode Therapeutics, Inc.
-18.5 M
LAST VALUE
-64.62%
2 YEAR CAGR
-110.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR